Nafamostat mesilate attenuates inflammation and apoptosis and promotes locomotor recovery after spinal cord injury

AIM: Spinal cord injury (SCI) leads to severe neural damage for which there is currently no effective treatment. Exploration of the neuroprotective effect among clinically approved drugs will speed up clinical translation of SCI. Nafamostat mesilate (NM) as a synthetic serine protease inhibitor has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Duan, Hui‐Quan, Wu, Qiu‐Li, Yao, Xue, Fan, Bao‐You, Shi, Hong‐Yu, Zhao, Chen‐Xi, Zhang, Yan, Li, Bo, Sun, Chao, Kong, Xiao‐Hong, Zhou, Xin‐Fu, Feng, Shi‐Qing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6489917/
https://ncbi.nlm.nih.gov/pubmed/29352519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12801
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados